Axsome Therapeutics, Inc.
COMPOSITIONS FOR DELIVERY OF REBOXETINE
Last updated:
Abstract:
Described herein are methods for the administration of reboxetine, or a pharmaceutically acceptable salt thereof, to a human being in need thereof, resulting in a first maximum plasma concentration and a second maximum plasma concentration, wherein the two maxima are separated by a time period of about 2 hours to about 6 hours.
Status:
Application
Type:
Utility
Filling date:
17 Jul 2019
Issue date:
19 Dec 2019